Advising the advisor: Tips for navigating the life sciences and regulatory environment
At the Intersection of Science and Law
English - April 18, 2022 17:30 - 31 minutes - 28.4 MBLife Sciences Science Technology covid19 fda mrna pfizer dlapiper law lawfirms legal pandemic vaccine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The moral imperative: Balancing innovation, regulation and prescription drug availability
Next Episode: The rise of global telehealth
DLA Piper managing partner Emilio Ragosa is joined by Kevin Sheridan, Joint Global Head of Healthcare Investment Banking at Jefferies LLC, to discuss the importance of advisors having an understanding of the life sciences industry in order to provide value-added advice on transactions, including public offerings and M&A.
See omnystudio.com/listener for privacy information.